Lenz Therapeutics shares hit a new 52-week high during Monday's session. The company announced the FDA accepted its new drug ...

LENZ Therapeutics said the submission for the treatment of presbyopia is supported by the positive data results from a Phase 3 study. Aceclidine is a new chemical entity in the U.S. and isn't approved ...

LENZ Therapeutics (LENZ) announced that the U.S. Food and Drug Administration, FDA, has accepted the Company’s New Drug Application, NDA, ...

The NDA submission for the treatment of presbyopia is supported by the positive data results from the pivotal Phase 3 CLARITY study. Aceclidine is a new chemical entity in the United States and is not ...

Leerink Partnrs lifted their FY2028 EPS estimates for LENZ Therapeutics in a research report issued on Tuesday, October 15th.

Analyst Price Forecast Suggests 43.41% Upside As of September 25, 2024, the average one-year price target for LENZ ...

Shares of Achieve Life Sciences (NASDAQ:ACHV), INmune Bio (NASDAQ:INMB), and LENZ Therapeutics (NASDAQ:LENZ) rose on Friday after the biotech trio received bullish recommendations from Raymond James.

SAN DIEGO, Sept. 30, 2024 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (Nasdaq: LENZ or “LENZ” or the “Company”), a late clinical-stage biopharmaceutical company focused on developing the ...

On Friday, Neumora Therapeutics Inc (NMRA) stock saw a decline, ending the day at $16.49 which represents a decrease of $-0.47 or -2.77% from the prior close of $16.96. The stock opened at $17 and ...

In terms of valuation, Neumora Therapeutics Inc’s market capitalization stands at $2.71 billion. Market cap represents the total value of all outstanding shares and is a key indicator of a company’s ...

Fintel reports that on September 27, 2024, Raymond James initiated coverage of LENZ Therapeutics (NasdaqGS:LENZ) with a Outperform recommendation. As of September 25, 2024, the average one-year ...

SAN DIEGO, Sept. 30, 2024 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (Nasdaq: LENZ or “LENZ” or the “Company”), a late clinical-stage biopharmaceutical company focused on developing the first and ...